Stay updated on Atezolizumab in Esophageal Cancer: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.

Latest updates to the Atezolizumab in Esophageal Cancer: Clinical Trial page
- Check2 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page now shows a 403 Forbidden error with a basic header and a Home link. This replaces the previous display of the trial's details, locations, and study information.SummaryDifference17%

- Check37 days agoChange DetectedThe locations count is updated to 166 with Siriraj Hospital (Bangkok, Thailand) removed from the list of sites. The study status has changed from Active, not recruiting to Completed.SummaryDifference0.3%

- Check51 days agoChange DetectedA new page revision tag has been added (Revision: v3.6.6). The previous revision tag (Revision: v3.6.5) has been removed.SummaryDifference0.0%

- Check58 days agoChange DetectedA Publications section has been added to the study page, including a PubMed citation for the related research and a note that publications are auto-filled from PubMed.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab in Esophageal Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.